Selective expansion of T cells expressing Vβ2 in toxic shock syndrome

Journal of Experimental Medicine

Volumn 172, Issue 3, 1990, Pages 981-984

  Choi, Yongwon ^b,c   Laferty, Joyce A ^a   Clements, Janice R ^b,c   Todd, James K ^d,e   Gelfand, Erwin W ^a,d   Kappler, John ^b,c,d   Marrack, Philippa ^b,c,d   Kotzin, Brian L ^a,b,d  

^a Departments of Pediatrics   (United States)

^b University of Colorado Anschutz Medical Campus   (United States)

^c HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

T LYMPHOCYTE RECEPTOR;

ARTICLE; CELL CULTURE; CLINICAL ARTICLE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; T LYMPHOCYTE; TOXIC SHOCK SYNDROME;

ANTIGENS, CD; ANTIGENS, CD4; ANTIGENS, CD8; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; HUMAN; IMMUNOGLOBULIN VARIABLE REGION; LONGITUDINAL STUDIES; RECEPTORS, ANTIGEN, T-CELL; REFERENCE VALUES; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0025033656     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.172.3.981     Document Type: Article

References (18)

1. Todd, J.K., M. Fishaut, F. Kapral, and T. Welch. 1978. Toxic shock syndrome associated with phage-group 1-staphylococci. Lancet. ii:1116.
2. Davis, J.P., P.J. Chesney, P.J. Wand, M. LaVenture, and the Investigation and Laboratory Team. 1980. Toxic shock syndrome: epidemiologic features, recurrence, risk factors, and prevention. N. Engl. J. Med. 303:1429.
3. Shand s, K.N., G.P. Schmid, B.B. Dan, D. Blum, R.J. Guidotti, NT. Hargrett, R.L. Anderson, D.L. Hill, C.V. Broome, J.D. Band, and D.W. Fraser. 1980. Toxic-shock syndrome in menstruating women: association with tampon use and Staphylococcal aureus and clinical features in 52 cases. N. Engl. J. Med. 303:1436.
4. Todd, J.K. 1988. Toxic shock syndrome. Clin. Microbiol. Rev. 1:432.
5. Chesney, P.J. 1989. Clinical aspects and spectrum of illness of toxic shock syndrome: overview. Rev. Infect. Dis. II(Suppl. 1):S1.
6. Reingold, A.L., NT. Hargrett, B.B. Dan, K.N. Shand s, B.Y. Strickland, and C.V. Broome. 1982. Nonmenstrual toxic shock syndrome: a review of 130 cases. Ann. Int. Med. 96:871.
7. Bergdoll, M.S., B.A. Crass, R.F. Reiser, R.N. Robbins, and J.P. Davis. 1981. A new staphylococcal enterotoxin, enterotoxin F, associated with toxic-shock-syndrome Staphylococcus aureus isolates. Lancet. i:1017.
8. Schlievert, P.M., K.N. Shands, B.B. Dan, G.P. Schmid, and R.D. Nishimura. 1981. Identification and characterization of an exotoxin from Staphylococcus aureus associated with toxic shock syndrome. J. Infect. Dis. 143:509.
9. Marrack, P., and J. Kappler. 1990. The staphylococcal en- terotoxins and their relatives. Science (Wash. DC). 248:705.
10. Kappler, J., B.L. Kotzin, L. Herron, E.W. Gelfand, R.D. Bigler, A. Boylston, S. Carrel, D.N. Posnett, Y. Choi, and P. Mar-rack. 1989. V/3-specific stimulation of human T cells by staphylococcal toxins. Science (Wash. DC). 244:811.
11. Choi, Y., B.L. Kotzin, L. Herron, J. Callahan, P. Marrack, and J. Kappler. 1989. Interaction of S. aureus toxin superantigens with human T cells. Proc Natl. Acad. Sci. USA. 86:8941.
12. Sprent, J., J.F.A.P. Miller, and G.F. Mitchell. 1971. Antigen-induced selective recruitment of circulating lymphocytes. Cell Immunol. 2:171.
13. Wilson, D.B., A. Marshak, and J.C. Howard. 1976. Specific positive and negative selection of rat lymphocytes reactive to strong histocompatibility antigens: activation with alloantigens in vitro and in vivo. J. Immunol. 116:1030.
14. Parsonnet, J. 1989. Mediators in the pathogenesis of toxic shock syndrome: overview. Rev. Infect. Dis. II(Suppl. 1):S263.
15. Beutler, R, and A. Cerami. 1987. Cachectin: more than a tumor necrosis factor. N. Engl. J. Med. 316:379.
16. Marrack, P., M. Blackman, E. Kushnir, and J. Kappler. 1990. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J. Exp Med. 171:455.
17. Nedwin, G.E., L.P. Svedersky, T.S. Bringman, M.A. Palladino, and D.V. Gpedel. 1985. Effect of interleukin 2, interferon-gamma, and mitogens on the production of tumor necrosis factors alpha and beta. J. Immunol. 135:2492.
18. Gaynor, E.R., L. Vitek, L. Sticklin, S.P. Creekmore, M.E. Fer-raro, J.X. Thomas, S.G. Fisher, and R.I. Fisher. 1988. The hemodynamic effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann. Int. Med. 109:953.